Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial.
Lai S, Li P, Liu X, Liu G, Xie T, Zhang X, Wang X, Huang J, Tang Y, Liu Z, Shen G, Li C, Lu F, Wang L, Jiang F, Sun C, Chen Y, Chen M.
Lai S, et al. Among authors: wang x, wang l.
Cancer Biol Med. 2024 Mar 4:j.issn.2095-3941.2023.0373. doi: 10.20892/j.issn.2095-3941.2023.0373. Online ahead of print.
Cancer Biol Med. 2024.
PMID: 38445445